Eli Lilly to Build Four U.S. Drug Plants in $27 Billion Expansion
Eli Lilly will spend at least $27 billion to build four new U.S. drug plants, bringing its total domestic investment to over $50 billion since 2020.
Eli Lilly will spend at least $27 billion to build four new U.S. drug plants, bringing its total domestic investment to over $50 billion since 2020.
